Clinical Research Physician – Incretins at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Scientific and medical training
Clinical expertise
Relevant clinical experience
Awareness of and adherence to local and international regulations, laws, guidance (FDA, ICH, CPMP, etc.), Good Clinical Practices (GCPs), company standards, Lilly policies and procedures, global quality standards, and the Principles of Medical Research

Responsibilities

Developing or contributing to the global and/or regional clinical/medical plan
Developing, conducting, and reporting clinical trials
Implementing global clinical trials in local affiliates/countries
Reporting adverse events as mandated by corporate patient safety
Reviewing protocols, study reports, publications, and data dissemination
Creating and updating labels, documents, and tools for product pricing, reimbursement, and access (PRA)
Submitting grant applications and contracts
Contacting regulatory and governmental agencies
Conducting outreach activities with thought leaders
Supporting demand realization
Serving as a scientific resource for study teams and departments
Ensuring compliance with all relevant regulations and guidelines

Skills

Clinical Trials

GCP

FDA Regulations

ICH Guidelines

Regulatory Compliance

Adverse Event Reporting

Protocol Development

Study Reports

Thought Leader Engagement

Medical Affairs

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free